e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Treatment and management of asthma in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Innovative dry powder inhaler (DPI) shows improved cost-effectiveness compared with current DPIs for asthma therapy in UK primary care
V. Thomas, A. Burden, J. von Ziegenweidt, S. Gould, C. Hutton, D. Price (Oackington, Aberdeen, United Kingdom)
Source:
Annual Congress 2013 –Treatment and management of asthma in primary care
Session:
Treatment and management of asthma in primary care
Session type:
Thematic Poster Session
Number:
3833
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Thomas, A. Burden, J. von Ziegenweidt, S. Gould, C. Hutton, D. Price (Oackington, Aberdeen, United Kingdom). Innovative dry powder inhaler (DPI) shows improved cost-effectiveness compared with current DPIs for asthma therapy in UK primary care. Eur Respir J 2013; 42: Suppl. 57, 3833
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs)
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Ease of use of a two-strip dry powder inhaler (DPI) to deliver fluticasone furoate/vilanterol (FF/VI) and FF alone in asthma
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Equivalence of an innovative multidose salmeterol/fluticasone dry powder inhaler vs comparator in paediatric asthma
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Use of a new dry powder inhaler to deliver umeclidinium/vilanterol in the treatment of COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI)
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014
Cardiovascular safety of extrafine beclomethasone/formoterol (BDP/FF) delivered via a novel dry powder inhaler (NEXThaler®) in COPD patients
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015
Canadian physicians are concerned about the use of inhaled corticosteroids (ICS) in COPD management
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Year: 2014
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
GENebu Project: home nebulizer use and maintenance in Italy
Source: Eur Respir J 2001; 18: 758-763
Year: 2001
Asthma management - The role of drug delivery
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
LATE-BREAKING ABSTRACT: Effectiveness of training session on the inhalation technique of the BA-pMDI Autohaler® (containing beclometasone) in daily practice.
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Inspiratory flow resistance of marketed dry powder inhalers (DPI)
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Impact of inhaler technique on patient outcomes in asthma patients using diskus in primary care
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Improved MDI inhaler technique observed in adult asthma patients with Web based education
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma
Source: International Congress 2016 – Asthma management
Year: 2016
Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
In whom should regular asthma controller therapy be initiated?
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept